Antitumor Efficacy of the Novel KIT Inhibitor IDRX-42 (Formerly M4205) in Patient- and Cell Line–Derived Xenograft Models of Gastrointestinal Stromal Tumor (GIST)Luna De Sutter, Patrick Schöffski|Clinical Cancer Research|2023Cited by 12